Problem statement: Answer the MCQ question.
Question: Which drug exhibits a 22.220% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a: CCN(C(=O)CN1CCOCC1)c1c(N)n(Cc2ccccc2)c(=O)[nH]c1=O
b: O=C(CCS(=O)(=O)c1ccc(Br)cc1)N1CCN(c2ccccc2F)CC1
Answer: a. CCN(C(=O)CN1CCOCC1)c1c(N)n(Cc2ccccc2)c(=O)[nH]c1=O
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCN(C(=O)CN1CCOCC1)c1c(N)n(Cc2ccccc2)c(=O)[nH]c1=O
CCN(C(=O)CN1CCOCC1)c1c(N)n(Cc2ccccc2)c(=O)[nH]c1=O
N-(6-amino-1-benzyl-2,4-dioxopyrimidin-5-yl)-N-ethyl-2-morpholin-4-ylacetamide